EXPERIMENT 15-16 POST LAB: SUMMARY OF THE E HEPATITIS VIRUSES AND THEIR ASSOCIATED SEROLOGICAL AND MOLECULAR MARKERS

Question 1

RNA Picornaviridae

Answer 1

HAV

Question 2

Fecal, oral

Answer 2

HAV
HEV

Question 3

Progression to Chronic State: No

Answer 3

HAV
HEV

Question 4

Progression to Chronic State: Yes

Answer 4

HBV
HCV
HDV

Question 5

DNA Hepadnaviridae

Answer 5

HBV

Question 6

Parental, sexual, perinatal

Answer 6

HBV
HCV

Question 7

RNA Flaviviridae

Answer 7

HCV

Question 8

RNA Genus Deltavirus

Answer 8

HDV

Question 9

RNA Hepeviridae

Answer 9

HEV

Question 10

Low risk of fulminant liver disease

Answer 10

HAV

Question 11

10 to 90 percent of cases may develop chronic hepatitis (depending on age), with increased risk for liver cirrhosis and hepatocellular carcinoma

Answer 11

HBV

Question 12

Eighty-five percent develop chronic infection, with increased risk of cirrhosis, hepatocellular carcinoma, or autoimmune manifestation

Answer 12

HCV

Question 13

Increased risk of developing fulminant hepatitis, cirrhosis, or hepatocellular carcinoma

Answer 13

HDV

Question 14

Fulminant liver failure in pregnant women

Answer 14

HEV

Question 15

Acute hepatitis A

Answer 15

IgM anti-HAV

Question 16

Immunity to hepatitis A

Answer 16

Total anti-HAV

Question 17

Detection of HAV in clinical, food, or water samples

Answer 17

HAV RNA

Question 18

Active hepatitis B infection
Active hepatitis B with high degree of infectivity

Answer 18

HBsAg

Question 19

Current or recent acute hepatitis B

Answer 19

IgM anti-HBc

Question 20

Current or recent acute hepatitis B

Answer 20

Total anti-HBc

Question 21

Recovery from hepatitis B

Answer 21

anti-HBe

Question 22

Immunity to hepatitis B

Answer 22

anti-HBs

Question 23

Current or past hepatitis C infection

Answer 23

Anti-HCV

Question 24

Current hepatitis C infection

Answer 24

HCV RNA

Question 25

viral may be used to monitor effectiveness of therapy

Answer 25

HCV RNA

Question 26

also used to determine HCV genotype

Answer 26

HCV RNA

Question 27

Acute or chronic hepatitis D

Answer 27

IgM-anti-HDV

Question 28

Recovery from hepatitis D or chronic hepatitis D

Answer 28

IgG-anti-HDV

Question 29

Active HDV infection; viral load may be used to monitor effectiveness of therapy

Answer 29

HDV RNA

Question 30

Current hepatitis E infection

Answer 30

IgM anti-HEV

Question 31

Current of part hepatitis E infection

Answer 31

IgG anti-HEV

Question 32

Current hepatitis E infection

Answer 32

HEV RNA

Question 33

Acute, atypical, or occult hepatitis B; viral load may be used to monitor effectiveness of therapy

Answer 33

anti-HBs